Conclusion:
Acquired EV is a recent and rare entity, occurring in conditions with
compromised cell-mediated immunity such as renal transplantation. The
number of renal-transplant recipients has significantly increased in
recent years which may lead to an increase in the prevalence of acquired
EV. Transplant recipients are at high risk of developing non-melanoma
skin cancers.16 It is important to recognize and
accurately diagnose acquired EV because its impact on the cancer risk
and its consequences on patient monitoring is still unknown. Cohort
studies are required with long-term follow-up and continued evaluation
to assess the relative risk for secondary skin cancers. The importance
of regular sunscreen application must be stressed. Physicians should
play a key role for the long-term dermatologic surveillance of this
high-risk population.